Novatek International is pleased to announce that Mr. Parsa Famili, President and CEO and Ms. Susan Cleary, Associate Directors of R&D at Novatek International have contributed to the most recent…
A very happy 2016 to all of our industry followers, clients, colleagues and friends! Novatek is entering into their 20th year serving the global pharmaceutical and biotech industries and we…
With global regulatory pressure increasing, pharmaceutical companies must prove that their processes are under control and that measures are in place to correct any problem that arises. Simply addressing an…
Earlier this week, Canada was pleased to welcome The Honorable Tony Abbott, Prime Minister of Australia. A dinner reception at The Fairmont Château Laurier, Ottawa was held in honor of…
The Southern California Discussion Group of the ASQ Biomedical Division Presents: Risk Based Environmental Monitoring (EM): How to use risk to ensure your EM Program is value added & efficient…
Novatek International organized an open forum with various Philippine Pharmaceutical Associations. Novatek’s objectives during this event were: To provide an update on global trends and guidelines (and present the Novatek…
Novatek International is very proud to announce that Mr. Aram Montazami, Vice president of R&D at Novatek International has contributed to the recent Springer publication: Biomedical Engineering: Health Care Systems,…
CDER RELEASES A NEW PET DRAFT GUIDANCE CDER has released as a DRAFT the following Guidance for Industry, “Media Fills for Validation of Aseptic Preparation for Positron Emission Tomography (PET)…
CDER NAMES THESE TEN (21 CFR 211) The following represent those most frequent Observations that CDER posted for fiscal year 2010 based on a total of 646 FDA Form 483.…
2011 PDA Annual Meeting San Antonio Texas USA Monday April 12, 2011 Novatek International speaks to David Matsuhiro, President, Cleanroom Compliance, Inc about a brand new class called Quality Systems…